title: Solitary pancreas transplantation. Experience with 62 consecutive cases.
abstract: OBJECTIVE
  To determine the safety and efficacy of solitary pancreas transplantation in the treatment of IDDM.
  
  
  METHODS
  A single-center retrospective case series of 62 consecutive solitary pancreas transplants (20 sequential pancreas after kidney, 42 pancreas transplants alone) performed in 57 adult IDDM patients was studied. Indications for solitary pancreas transplantation were 1) the presence of two or more overt diabetic complications and/or 2) glucose hyperlability with hypoglycemic unawareness and impaired quality of life. The recipient group consisted of 31 men and 26 women with a mean age of 38 years (range 25-62) and a mean duration of diabetes of 26 years (range 14-52). Mean pretransplant glycohemoglobin level was 9.9 +/- 2.6%. Organ acceptance was restricted to ideal donors and man-dated a minimum of a two-antigen match (mean human leukocyte antigen ABDR match 2.7). The mean cold ischemia time was 16.6 h. Whole-organ pancreas transplantation was performed with bladder drainage by the duodenal segment technique. All patients were managed with either triple or quadruple immunosuppression. Monitoring included prospective urine cytology as well as cystoscopic transduodenal needle biopsies.
  
  
  RESULTS
  The mean length of initial hospital stay was 18 days, and mean hospital charges were $106,341. The incidences of rejection, infection, and surgical complications were 70, 55, and 47%, respectively. Overall patient and graft survival rates were 86 and 52%, respectively, with a mean follow-up of 28 months. All patients with functioning grafts had excellent metabolic control (mean glycohemoglobin level 5.1%) and achieved good rehabilitation.
  
  
  CONCLUSIONS
  Despite morbidity, solitary pancreas transplantation can be performed with improving success, can enhance quality of life, and can offer an opportunity to arrest secondary diabetic complications.
authors.affiliation: Department of Surgery, University of Nebraska Medical Center, Omaha, USA.
authors.forename: R J
authors.initials: RJ
authors.lastname: Stratta
authors.forename: L G
authors.initials: LG
authors.lastname: Weide
authors.forename: R
authors.initials: R
authors.lastname: Sindhi
authors.forename: D
authors.initials: D
authors.lastname: Sudan
authors.forename: J T
authors.initials: JT
authors.lastname: Jerius
authors.forename: J L
authors.initials: JL
authors.lastname: Larsen
authors.forename: K
authors.initials: K
authors.lastname: Cushing
authors.forename: M T
authors.initials: MT
authors.lastname: Grune
authors.forename: S J
authors.initials: SJ
authors.lastname: Radio
mesh_terms: D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D016381:Islets of Langerhans Transplantation / Q000191:economics / Q000379:methods* / Q000534:rehabilitation; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012449:Safety; D015996:Survival Rate